These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9045944)

  • 1. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
    Jpn J Cancer Res; 1996 Nov; 87(11):1153-9. PubMed ID: 9045944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of undifferentiated-type gastric carcinoma.
    Tamura G; Sato K; Akiyama S; Tsuchiya T; Endoh Y; Usuba O; Kimura W; Nishizuka S; Motoyama T
    Lab Invest; 2001 Apr; 81(4):593-8. PubMed ID: 11304579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.
    Tamura G; Yin J; Wang S; Fleisher AS; Zou T; Abraham JM; Kong D; Smolinski KN; Wilson KT; James SP; Silverberg SG; Nishizuka S; Terashima M; Motoyama T; Meltzer SJ
    J Natl Cancer Inst; 2000 Apr; 92(7):569-73. PubMed ID: 10749913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.
    Machado JC; Soares P; Carneiro F; Rocha A; Beck S; Blin N; Berx G; Sobrinho-Simões M
    Lab Invest; 1999 Apr; 79(4):459-65. PubMed ID: 10211998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.
    Becker KF; Atkinson MJ; Reich U; Becker I; Nekarda H; Siewert JR; Höfler H
    Cancer Res; 1994 Jul; 54(14):3845-52. PubMed ID: 8033105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin gene mutations in human gastric carcinoma cell lines.
    Oda T; Kanai Y; Oyama T; Yoshiura K; Shimoyama Y; Birchmeier W; Sugimura T; Hirohashi S
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1858-62. PubMed ID: 8127895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin gene mutations in signet ring cell carcinoma of the stomach.
    Muta H; Noguchi M; Kanai Y; Ochiai A; Nawata H; Hirohashi S
    Jpn J Cancer Res; 1996 Aug; 87(8):843-8. PubMed ID: 8797891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The common 18-base pair deletion at codons 418-423 of the E-cadherin gene in differentiated-type adenocarcinomas and intramucosal precancerous lesions of the stomach with the features of gastric foveolar epithelium.
    Endoh Y; Tamura G; Watanabe H; Ajioka Y; Motoyama T
    J Pathol; 1999 Oct; 189(2):201-6. PubMed ID: 10547575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma.
    Fukudome Y; Yanagihara K; Takeichi M; Ito F; Shibamoto S
    Int J Cancer; 2000 Nov; 88(4):579-83. PubMed ID: 11058874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
    Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of mutated E-cadherin in peritoneal lavage specimens from patients with diffuse-type gastric carcinoma.
    Schuhmacher C; Becker KF; Reich U; Schenk U; Mueller J; Siewert JR; Höfler H
    Diagn Mol Pathol; 1999 Jun; 8(2):66-70. PubMed ID: 10475380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation, loss of heterozygosity, and recombination of the p53 gene in mouse forestomach tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline.
    Ushijima T; Makino H; Okonogi H; Hosoya Y; Sugimura T; Nagao M
    Mol Carcinog; 1995 Jan; 12(1):23-30. PubMed ID: 7818762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas.
    Sentani K; Oue N; Kondo H; Kuraoka K; Motoshita J; Ito R; Yokozaki H; Yasui W
    Pathobiology; 2001; 69(6):315-20. PubMed ID: 12324708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas.
    Becker KF; Atkinson MJ; Reich U; Huang HH; Nekarda H; Siewert JR; Höfler H
    Hum Mol Genet; 1993 Jun; 2(6):803-4. PubMed ID: 8353498
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
    Shi Y; Zou M; Farid NR; al-Sedairy ST
    Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
    Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
    Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the E-cadherin gene in human gynecologic cancers.
    Risinger JI; Berchuck A; Kohler MF; Boyd J
    Nat Genet; 1994 May; 7(1):98-102. PubMed ID: 8075649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
    Kim HS; Hong EK; Park SY; Kim WH; Lee HS
    Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ile-Leu substitution (I415L) in germline E-cadherin gene (CDH1) in Japanese familial gastric cancer.
    Wang Y; Song JP; Ikeda M; Shinmura K; Yokota J; Sugimura H
    Jpn J Clin Oncol; 2003 Jan; 33(1):17-20. PubMed ID: 12604719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations in thyroid tumor progression: association with p53 gene mutations.
    Ito T; Seyama T; Mizuno T; Tsuyama N; Hayashi Y; Dohi K; Nakamura N; Akiyama M
    Jpn J Cancer Res; 1993 May; 84(5):526-31. PubMed ID: 8100564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.